Insider Ledger
NMRA insider buying and SEC filings, explained
Neumora Therapeutics, Inc. · CIK 1885522
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$298K
Planned sales (10b5-1)
$313K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 17, 2026 | Sale | Daljit Singh Aurora (President / COO) sold 146,706 shares directly and indirectly at about $1.50 ($220K). Direct holdings down 65% to 48,750 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 19, 2026 |
| Feb 17, 2026 | Sale | Daljit Singh Aurora (President / COO) sold 6,165 shares at $3.56 ($22K). Holdings down 7% to 82,770 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 19, 2026 |
| Feb 17, 2026 | Sale | Joshua Pinto (President / COO) sold 5,967 shares at $3.54 ($21K). Holdings down 9% to 57,783 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 19, 2026 |
| Feb 17, 2026 | Sale | Paul L. Berns (CEO and Director) sold 9,819 shares at about $3.51 ($34K). Holdings down <1% to 7,395,185 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 19, 2026 |
| Feb 17, 2026 | Planned (10b5-1) | Michael Lee Milligan (CFO) sold 1,436 shares at $3.57 ($5K), marked as a 10b5-1 plan trade. Holdings down 6% to 21,034 shares. | SEC filing Filed Feb 19, 2026 |
| Nov 11, 2025 | Planned (10b5-1) | Daljit Singh Aurora (President / COO) sold 114,703 shares indirectly at about $2.68 ($307K), marked as a 10b5-1 plan trade. Indirect holdings down 100% to 0 shares. | SEC filing Filed Nov 13, 2025 |
18 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
| Tag | Items | Filed | Source |
|---|---|---|---|
| Red flag: listing deficiency notice Detected from the filing text | 8-K Item 3.01 | Oct 30, 2026, 4:05 PM ET | SEC filing |
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Oct 30, 2026, 4:05 PM ET 8-K | Delisting or listing-rule notice (Item 3.01) | Red flag: listing deficiency notice Detected from the filing text | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow NMRA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.